top of page

Treatment Developments

The Treatment of Hepatoblastoma: Its evolution and the current status as per SIOPEL trials
Pediatric Hepatoblastoma: diagnosis and treatment
Cisplatin vs. Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4) a prospective, single-arm, feasibility study
Redefining the Role of Doxorubicin for the Treatment of Children with Hepatoblastoma
Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children
Successful Treatment of Childhood High-Risk Hepatoblastoma with Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
Outcomes of pulmonary metastasis in hepatoblastoma - is the prognosis always poor?
Relapsed Hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy
Current and Future Management Strategies for Relapsed or Progressive Heptoblastoma
Relapse in hepatoblastoma patients: Clinical characteristics and outcome - Experience of the International Childhood Liver Tumor Strategy Group (SIOPEL)
Relapse & Metastasis
bottom of page